Cyclin D1 gene expression in human cervical neoplasia

Modern Pathology

Volumn 9, Issue 4, 1996, Pages 418-425

  Nichols, Guy E ^b   Williams, Michael E ^b   Gaffey, Michael J ^b   Stoler, Mark H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE

Author keywords

Cervical cancer; Cyclin D1; Human papillomavirus; In situ hybridization; Squamous intraepithelial lesion

Indexed keywords

CYCLINE; RETINOBLASTOMA TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CARCINOMA; CYCLIN D1; CYCLINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 0030002363     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Hirama T, Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841, 1995
2. Sherr CJ: Mammalian G1 cyclins. Cell 73:1059, 1993
3. Hinds PW, Dowdy SF, Eaton EN, et al.: Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 91:709, 1994
4. Lovec H, Sewing A, Lucibello FC, et al.: Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: Link between cell cycle control and malignant transformation. Oncogene 9:323, 1994
5. Zucca E, Stein H, Coiffer B: European lymphoma task force (ELTF): Report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 5:507, 1994
6. Swerdlow SH, Yang WI, Zukerberg LR, et al.: Expression of cyclin D1 protein in cetrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol 26:999, 1995
7. Rosenberg CL, Wong E, Petty EM, et al..: PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A 88:9638, 1991
8. Yang W-I, Zukerberg LR, Motokura T, et al.: Cyclin D1 (Bcl-1 PRAD-1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145:86, 1994
9. Rosenberg CL, G. KH, Shows TB, et al.: Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 6:449, 1991
10. Schuuring E, Verhoeven E, Mooi WJ, et al.: Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355, 1992
11. Karlseder J, Zeillinger R, Schneeberger C, et al.: Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes, Chromosomes Cancer 9:42, 1994
12. Proctor AJ, Combs LM, Cairns JP, et al.: Amplification at chromosome 11q13 in transitional cell tumors of the bladder. Oncogene 6:789, 1991
13. Foulkes WD, Campbell IG, Stamp GWH, et al.: Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br J Cancer 67:268, 1993
14. Williams ME, Gaffey MJ, Weiss LM, et al.: Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 119:1238, 1993
15. Gaffey MG, Frierson HF, Williams ME: Chromosome 11q13, c-erb-B-2, and c-myc amplification in invasive breast carcinoma: Clinicopathologic correlations. Mod Pathol 6:654, 1993
16. Williams ME, Swerdlow SH, Rosenberg CL, et al.: Centrocytic lymphoma: A B-cell non-Hodgkin's lymphoma characterized by chromosome 11 bcl-1 and PRAD 1 rearrangements. Curr Top Microbiol Immunol 182:325, 1992
17. Motokura T, Bloom T, Kim HG, et al.: A novel cyclin encoded by a bcl-1-linked candidate oncogene [see comments]. Nature 350:512, 1991
18. Lukas J, Pagano M, Staskova Z, et al.: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9:707, 1994
19. Ewen ME, Sluss HK, Sherr CJ, et al.: Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487, 1993
20. Dowdy SF, Hinds PW, Louie K, et al.: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499, 1993
21. Suzuki-Takahashi I, Kitagawa M, Saijo M, et al.: The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. Oncogene 10:1691, 1995
22. Crum CP: Genital papillomavirus and related neoplasms: Causation, diagnosis, and classification. Mod Pathol 7:138, 1994
23. Demeter LM, Stoler MH, Broker TR, et al.: Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions. Hum Pathol 25:343, 1994
24. Wright TC, Kurman RJ, Ferenczy A: Precancerous lesions of the cervix. In Blaustein's Pathology of the Female Genital Tract, edited by Kurman RJ, Ed 4, pp 229-78. New York, Springer-Verlag, 1994
25. Munger K, Phelps WC, Bubb V, et al.: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417, 1989
26. Arends MJ, Wyllie AJ, Bird CC: Papillomavirus and human cancer. Hum Pathol 21:686, 1990
27. Lukas J, Muller H, Bartkova J, et al.: DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 125:625, 1994
28. Kurzock R, Ku S, Talpaz M: Abnormalities in the PRAD1 (CYCLIN D1 BCL-1) oncogene are frequent incervical and vulvar squamous cell carcinoma cell lines. Cancer 75:584, 1995
29. Angerer LM, Stoler MH, Angerer RC: In situ hybridization with RNA probes: An annotated recipe. In In Situ Hybridization: Applications to Neurobiology, edited by Valentino KL, Eberwine JH, Barchas JD, pp 42-70. New York, Oxford University Press, 1987
30. Stoler MH, Broker TR: In situ hybridization detection of human papillomavirus DNA and messenger RNA in genital condylomas and a cervical carcinoma. Hum Pathol 17:1250, 1986
31. Motokura T and Arnold A: PRAD1/cyclin D1 proto-oncogene: Genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosom Cancer 7:89, 1993
32. Segal GH, Shick E, Fishleder AJ, et al.: In situ hybridization analysis of lymphoproliferative disorders: Assessment of clonality by immunoglobulin light chain messenger RNA expression. Diagn Mol Pathol 3:170, 1994
33. Gaffey MJ, Iezzoni JC, Boyd JC, et al.: Cyclin D1 (PRAD1 CCND1) and glutathione-S-transferase gene expression in head and neck squamous cell carcinoma. Hum Pathol 26: 1221, 1995
34. Marx J: How cells cycle towards cancer. Science 263:319, 1994
35. Xiong Y, Zhang H, Beach D: D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505, 1992
36. Muller H, Lukas J, Schneider A, et al.: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci U S A 91:2945, 1994
37. Stoler MH, Rhodes CR, Whitbeck A, et al.: Human papillomavirus type 16 and 18 gene expression in cervical neoplasia. Hum Pathol 23:117, 1992
38. Munger K, Werness BA, Dyson N, et al.: Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8:4099, 1989
39. Xiong Y, Menninger J, Beach D, et al.: Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 13:575, 1992
40. Motokura T, Keyomarsi K, Kronenberg HM, et al: Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chem 267:20412, 1992
41. Williams ME, Nichols GE, Swerdlow SH, et al.: In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma. Ann Oncol 6:297, 1995
42. Scheffner M, Werness BA, Huibregtse JM, et al.: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129, 1990
43. Marx J: How p53 suppresses cell growth. Science 262:1644, 1993
44. Li Y, Jenkins CW, Nichols MA, et al.: Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261, 1994